Announcements & Circulars-Alphamab Oncology

English 中文简体中文繁体

English 中文简体中文繁体

Investors

Information Disclosure

Listing Documents

Financial Reports

Announcements & Circulars

Company Presentation

Corporate Governance

Stock Information

Corporate Communications

Email Subscription

Announcements & Circulars

The announcement begins in December 2019

FORM OF PROXY FOR USE AT THE ANNUAL GENERAL MEETING TO BE HELD ON THURSDAY, JUNE 12, 2025 2025-05-20
NOTICE OF ANNUAL GENERAL MEETING 2025-05-20
(1) PROPOSED GRANTING OF GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE NEW SHARES (INCLUDING RESELL OR TRANSFER TREASURY SHARES); (2) PROPOSED RE-ELECTION OF THE RETIRING DIRECTORS; (3) PROPOSED RE-APPOINTMENT OF AUDITORS; AND (4) NOTICE OF ANNUAL GENERAL MEETING 2025-05-20
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2025 2025-05-07
VOLUNTARY ANNOUNCEMENT - THE INTERIM ANALYSIS OF A PIVOTAL PHASE II/III CLINICAL TRIAL OF KN026 HAS MET THE PRIMARY ENDPOINT OF PFS 2025-04-30
VOLUNTARY ANNOUNCEMENT - RESEARCH UPDATES OF JSKN021 AND JSKN022 FOR PRESENTATION AT 2025 AACR ANNUAL MEETING 2025-04-30
2024 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT 2025-04-28
(1) GRANT OF SHARE OPTIONS UNDER THE POST-IPO SHARE OPTION SCHEME; AND (2) GRANT OF AWARD SHARES UNDER THE RESTRICTED SHARE AWARD SCHEME 2025-04-23
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2025 2025-04-03
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2024 2025-03-25